Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices 5091 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

Dated: January 25, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–1901 Filed 1–29–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Office 

of AIDS Research Advisory Council. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Office of AIDS 

Research Advisory Council. 

Date: March 18, 2010. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: The theme of the meeting will be 

‘‘HIV/AIDS and Aging.’’ The meeting will 

address issues related to: increased rates of 

new infections among older adults; impact of 

long-term use of antiretroviral therapies in 

HIV-infected individuals; and premature 

aging in HIV-infected individuals. An update 

also will be provided on the OARAC 

Working Groups for HIV Treatment and 

Prevention Guidelines. 

Place: National Institutes of Health, 5635 

Fishers Lane, Rockville, MD 20852. 

Contact Person: Christina Brackna, 

Coordinator, Program Planning and Analysis, 

Office of Aids Research, Office of the 

Director, NIH, 5635 Fishers Lane MSC 9310, 

Suite 4000, Rockville, MD 20852, (301) 402– 

8655, cm53v@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Centers home page: http:// 

www.oar.nih.gov, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: January 25, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–1897 Filed 1–29–10; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 

Research Special Emphasis Panel (SEP) 

meeting. 

A Special Emphasis Panel is a group 

of experts in fields related to health care 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10 (d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for the ARRA: Limited 

Competition ‘‘NRSA CE Development 

Award’’ (T32) applications are to be 

reviewed and discussed at this meeting. 

These discussions are likely to reveal 

personal information concerning 

individuals associated with the 

applications. This information is 

exempt from mandatory disclosure 

under the above-cited statutes. 

SEP Meeting on: ARRA: Limited 

Competition ‘‘NRSA CE Development Award’’ 

(T32) 

Date: March 3, 2010 (Open on March 3 

from 1 p.m. to 1:15 p.m. and closed for the 

remainder of the meeting). 

Place: Hilton Rockville Executive Meeting 

Center, 1750 Rockville Pike, Madison 

Conference Room, Rockville, Maryland 

20850. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

Dated: January 25, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–1896 Filed 1–29–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meetings 

In accordance with section 10(d) of 

the Federal Advisory Committee Act as 

amended (5 U.S.C., Appendix 2), the 

Agency for Healthcare Research and 

Quality (AHRQ) announces meetings of 

scientific peer review groups. The 

subcommittees listed below are part of 

the Agency’s Health Services Research 

Initial Review Group Committee. 

The subcommittee meetings will be 

closed to the public in accordance with 

the Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications are to be reviewed and 

discussed at these meetings. These 

discussions are likely to involve 

information concerning individuals 

associated with the applications, 

including assessments of their personal 

qualifications to conduct their proposed 

projects. This information is exempt 

from mandatory disclosure under the 

above-cited statutes. 

1. Name of Subcommittee: Health Care 

Technology and Decision Sciences. 

Date: February 23–25, 2010 (Open from 8 

a.m. to 8:15 a.m. on February 23 and closed 

for remainder of the meeting). 

Place: Marriott Bethesda North Hotel & 

Conference Center, 5701 Marinelli Road, 

Forest Glen Conference Room, Bethesda, MD 

20852. 

2. Name of Subcommittee: Health Systems 

Research. 

Date: February 24–25, 2010 (Open from 8 

a.m. to 8:15 a.m. on February 24 and closed 

for remainder of the meeting). 

Place: Marriott Bethesda North & 

Conference Center, 5701 Marinelli Road, 

Linden Oak Conference Room, Bethesda, MD 

20852. 

3. Name of Subcommittee: Health Care 

Quality and Effectiveness Research. 

Date: March 3–4, 2010 (Open from 8:30 

a.m. to 8:45 a.m. on March 3 and closed for 

remainder of the meeting). 


jlentini on DSKJ8SOYB1PROD with NOTICES
5092 Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices 

Place: Hilton Rockville Executive Meeting 

Center, 1750 Rockville Pike, Plaza 3 

Conference Room, Rockville, Maryland 

20850. 

4. Name of Subcommittee: Health Care 

Research Training. 

Date: March 4–5, 2010 (Open from 8 a.m. 

to 8:15 a.m. on March 4 and closed for 

remainder of the meeting). 

Place: Hilton Rockville Executive Meeting 

Center, 1750 Rockville Pike, Madison 

Conference Room, Rockville, Maryland 

20850. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of the meetings 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Suite 

2000, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for these meetings are 

subject to change as priorities dictate. 

Dated: January 21, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–1880 Filed 1–29–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SRO 

Conflict SEP: Vector Biology. 

Date: February 11, 2010. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont San Francisco, 950 

Mason Street, San Francisco, CA 94108. 

Contact Person: John C. Pugh, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1206, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

2398, pughjohn@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Stroke, Traumatic Brain Injury, and 

Neurovascular Pathologies. 

Date: February 25, 2010. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Kevin Walton, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5200, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1785, kevin.walton@nih.hhs.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 26, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–2032 Filed 1–29–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. 

Application of Emerging Technologies and 

Biospecimen Sciences. 

Date: February 24–25, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Scientific Review Officer, 

Special Review and Logistics Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 6116 Executive 

Boulevard, Room 8059, Bethesda, MD 20892– 

8329, 301–496–7904, decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. R13 

Conference Grants Review, 

Date: February 25, 2010. 

Time: 1 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 8041, Rockville, 

MD 20852 (Telephone Conference Call). 

Contact Person: Bratin K. Saha, PhD, 

Scientific Review Officer, Program 

Coordination and Referral Branch, Division 

of Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8041, Bethesda, MD 20892, 301–402– 

0371. sahab@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

Quantitative Cell-Based Imaging for Clinical 

Diagnosis and Treatment. 

Date: February 25, 2010. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 706, Rockville, 

MD 20852 (Teleconference Meeting). 

Contact Person: Kenneth L. Bielat, PhD, 

Scientific Review Officer, Special Review 

Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 7147, Bethesda, 

MD 20892–8329, 301–496–7576, 

bielatk@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Facilitating 

the Transfer of Statistical Methodology into 

Practice. 

Date: March 3, 2010. 

Time: 11 a.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 707, Rockville, 

MD 20852 (Telephone Conference Meeting). 

Contact Person: Marvin L Salin, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 7073, 

Bethesda, MD 20892–8329 301–496–0694, 

msalin@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

Development of Cancer Proteomics Reagents, 

Date: March 9, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: The Legacy Hotel and Meeting 

Center, 1775 Rockville Pike, Rockville, MD 

20852, 

Contact Person: Zhiqiang Zou, M.D., PhD, 

Scientific Review Officer, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8050A, Bethesda, MD 

20852, 301–402–9415, zouzhiq@mail.nih.gov. 


jlentini on DSKJ8SOYB1PROD with NOTICES